iBio
IBIO
#9836
Rank
NZ$77.65 M
Marketcap
NZ$3.45
Share price
1.52%
Change (1 day)
-17.30%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2025 (TTM): NZ-$2.63

According to iBio's latest financial reports the company's current EPS (TTM) is NZ-$2.65. In 2024 the company made an earnings per share (EPS) of NZ-$11.17 an increase over its 2023 EPS that were of NZ-$182.45.

EPS history for iBio from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$2.63-76.45%
2024NZ-$11.17-93.88%
2023NZ-$182.45-8.14%
2022NZ-$198.6192.67%
2021NZ-$103.09-80.33%
2020NZ-$524.02-35.11%
2019NZ-$807.51-38.96%
2018NZ-$1,323-6.1%
2017NZ-$1,40936.67%
2016NZ-$1,03133.33%
2015NZ-$773.1450%
2014NZ-$515.43-53.85%
2013NZ-$1,117-7.14%
2012NZ-$1,203-64.1%
2011NZ-$3,35077.27%
2010NZ-$1,890144.44%
2009NZ-$773.1412.93%
2008NZ-$684.6412.2%
2007NZ-$610.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Genocea Biosciences
GNCA
NZ-$0.89-66.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.42-191.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$17.94-777.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$13.69 417.53%๐Ÿ‡บ๐Ÿ‡ธ USA